by Mathieu Ranger | 2 May, 2026 | Biotech Perspectives
Back to Ideas On journey mapping The customer journey map is nearly ubiquitous in the modern enterprise. Historically, companies were organized around functions (customer service, supply chain, billing), or individual products and services. The result was that when...
by Mathieu Ranger | 1 Apr, 2026 | Biotech Perspectives
Back to Ideas The case for early investment in rare disease state education When rare disease-focused biotech and pharma companies invest in disease state education (DSE), they have the opportunity to meaningfully improve patient experience, while also building a...
by Mathieu Ranger | 25 Mar, 2026 | Biotech Perspectives
Back to Ideas 5 tips for safely using LLMs to get medical advice As a team focused on improving patient experience, we’ve always paid attention to how and where patients seek education in their disease and treatment journey. With artificial intelligence in the...
by Mathieu Ranger | 3 Feb, 2026 | Biotech Perspectives
Back to Ideas A new approach to clinical trials On January 12, the FDA shared draft guidance that may fundamentally speed up how new medicines reach patients through clinical trial analysis. Based on our reading of Pratik Pawar’s Vox article, the guidance may...
by Michelle | 31 Jan, 2026 | Biotech Perspectives
Back to Ideas Why building awareness for rare disease clinical trials matters Among the patient stories shared in the NORD 2022 Voice of the Patient Report on Post-Transplant Lymphoproliferative Disorder, one story in particular gave us pause. In it, a patient...
by Michelle | 13 Nov, 2025 | Biotech Perspectives
Back to Ideas Improving patient experience: a multidimensional measurement framework As patient experience experts, we understand this concept as multi-dimensional and extending far beyond just “treating” patients. Rather, it encompasses all interactions that a...
